Two More Brands of Eye Drops Recalled Over Infection Risks
TUESDAY, March 7, 2023 (HealthDay News) -- U.S. federal health officials have issued recall notices for two more brands of eye drops.
In the latest round of recalls, the U.S. Food and Drug Administration posted notices after the companies voluntarily pulled several lots of their eye drops from the market.
The companies involved in the recalls are Phoenix-based Pharmedica and Florida-based Apotex.
Pharmedica is recalling its Purely Soothing 15 percent MSM Drops meant to treat eye irritation. The two lots were pulled because of "nonsterility" and "risk of eye infections that could result in blindness," the company said. People who have the eye drops should immediately stop using them and return them to the store where they bought them, the company added.
Meanwhile, Apotex is recalling six lots of prescription eye drops distributed as Brimonidine Tartrate Ophthalmic Solution, 0.15 percent. They were sold between April 2022 and February 2023. These eye drops are meant to treat glaucoma. Unfortunately, some of the eye drop bottles have cracks in the caps, the company said.
Related Posts
Su hijo adolescente puede prepararse para la temporada deportiva de estas cinco formas
VIERNES, 21 de julio de 2023 (HealthDay News) -- Los deportes competitivos...
One Big Factor for Survival After Spinal Cord Injury: Resilience
TUESDAY, Oct. 19, 2021 (HealthDay News) -- Survivors of spinal cord injuries who...
CDC Close to New Guidance on COVID Restrictions
THURSDAY, Feb. 24, 2022 (HealthDay News) -- Updated criteria to guide COVID-19...
Health Highlights: April 27, 2023
Exercise could be an antidote to addiction. Investigators who analyzed 43...